Physician profile
Nadia Megahed
NPI 1457706319
$5,748.03
in general payments reported to CMS, 2019-2025
8 companies · $411 in 2025
The $411 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $247 · 2021: $580 · 2022: $2,480 · 2023: $1,463 · 2024: $567 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,700 · Travel and Lodging: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,700.29 |
| Travel and Lodging | $740.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,234.46 | 2020-2025 | Solyx Sis System, Upsylon |
| Intuitive Surgical, INC. | $1,694.90 | 2022 | |
| Coloplast Corp | $244.37 | 2024-2025 | |
| Medtronic, INC. | $233.59 | 2022-2024 | Interstim |
| Axonics, INC. | $227.46 | 2021-2023 | Axonics |
| Sumitomo Pharma America, INC. | $44.45 | 2023 | Gemtesa |
| Applied Medical Resources Corporation | $43.63 | 2025 | |
| Laborie Medical Technologies Corp. | $25.17 | 2024 | Eclipse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Megahed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.